Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Oncotarget|March 24, 2018
Quantitative mass spectrometry analysis reveals a panel of nine proteins as diagnostic markers for colon adenocarcinomasApurva Atak, Samiksha Khurana, Kishore Gollapalli, et al.Frontiers in Microbiology|October 31, 2024
Effect of conservation agriculture on soil fungal diversity in rice-wheat-greengram cropping system in eastern Indo-Gangetic plains of South AsiaRakesh Kumar, Jaipal Singh Choudhary, Sushanta Kumar Naik, et al.Circulation|May 17, 2006
High-resolution quantitative computed tomography demonstrating selective enhancement of medium-size collaterals by placental growth factor-1 in the mouse ischemic hindlimbWeiming Li, Weiqun Shen, Robert Gill, et al.Health Science Reports|June 27, 2024
Subclinical leaflet thrombosis and anticoagulation strategy following trans-catheter aortic valve replacement: A systematic reviewSingam Shashank, Lalitha Devi Balireddi, Pugazhendi Inban, et al.Frontiers in Microbiology|July 24, 2023
Influence of conservation agriculture-based production systems on bacterial diversity and soil quality in rice-wheat-greengram cropping system in eastern Indo-Gangetic Plains of IndiaRakesh Kumar, Jaipal Singh Choudhary, Sushanta Kumar Naik, et al.Journal of Medicinal Chemistry|November 14, 2003
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonistYanping Xu, Daniel Mayhugh, Ashraf Saeed, et al.Omics : a Journal of Integrative Biology|January 25, 2014
Ready to put metadata on the post-2015 development agenda? Linking data publications to responsible innovation and science diplomacyVural Özdemir, Eugene Kolker, Peter J Hotez, et al.Cell Chemical Biology|July 2, 2026
Mechanistic dissection of SMARCA2/4 molecular glues reveals programmable switching between DCAF16 and FBXO22Milad Rouhimoghadam, Christie J Kang, Jackson A Gartman, et al.Journal of Medicinal Chemistry|February 1, 2024
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell MalignanciesDaniel W Robbins, Mark A Noviski, Ying Siow Tan, et al.Frontiers in Medicine|September 6, 2021
Recent Progress in Lyme Disease and Remaining ChallengesJason R Bobe, Brandon L Jutras, Elizabeth J Horn, et al.Pageof 15